Want to join the conversation?
$FINL expects its streamlining and optimization actions to generate net cost savings of approx. $6MM on an annualized basis. The company will begin to benefit from these savings in 4Q17 by approx. $1MM. $FINL also expects to incur severance-related charges and other costs in 3Q17.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.